Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vascular Inflammation in Psoriasis - Extension Study

Trial Profile

Vascular Inflammation in Psoriasis - Extension Study

Phase of Trial: Phase IV

Latest Information Update: 28 May 2018

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Plaque psoriasis
  • Focus Biomarker; Pharmacodynamics
  • Acronyms VIP-E
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 14 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 11 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top